ストックスクリーナーアプリを入手
9.55
2.35%
-0.23
アフターアワーズ：
9.35
-0.20
-2.09%
前日終値:
$9.78
開ける：
$9.3
24時間の取引高:
3.37M
Relative Volume:
2.51
時価総額：
$1.54B
収益：
$363.55M
当期純損益:
$-78.68M
株価収益率:
-19.10
EPS:
-0.5
ネットキャッシュフロー:
$50.74M
1週間 パフォーマンス:
-3.63%
1か月 パフォーマンス:
-19.41%
6か月 パフォーマンス:
-13.89%
1年 パフォーマンス:
-46.20%
1日の値動き範囲:
$9.21
$9.72
1週間の範囲:
$9.21
$10.31
52週間の値動き範囲:
$9.21
$19.18
Certara Inc Stock (CERT) Company Profile
名前
Certara Inc
セクター
電話
(415) 237-8272
住所
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
CERT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
9.55 | 1.54B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
213.68 | 34.76B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
51.24 | 9.61B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
42.58 | 7.33B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
78.80 | 6.82B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.93 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-27 | 開始されました | TD Cowen | Buy |
| 2024-09-27 | アップグレード | UBS | Neutral → Buy |
| 2024-04-10 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | 開始されました | JMP Securities | Mkt Perform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | UBS | Neutral |
| 2023-12-05 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | ダウングレード | Jefferies | Buy → Hold |
| 2023-08-10 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | 開始されました | Stephens | Overweight |
| 2023-04-03 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-12-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | 開始されました | Berenberg | Buy |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-01 | 開始されました | Piper Sandler | Overweight |
| 2022-01-11 | アップグレード | Jefferies | Hold → Buy |
| 2021-08-05 | 再開されました | Credit Suisse | Neutral |
| 2021-07-23 | 開始されました | Robert W. Baird | Outperform |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-06 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-01-05 | 開始されました | BofA Securities | Buy |
| 2021-01-05 | 開始されました | Credit Suisse | Neutral |
| 2021-01-05 | 開始されました | Jefferies | Hold |
| 2021-01-05 | 開始されました | William Blair | Outperform |
すべてを表示
Certara Inc (CERT) 最新ニュース
Certara stock hits 52-week low at $9.3 amid market challenges By Investing.com - Investing.com South Africa
Analysts Predict How High Certara Inc (CERT) Will Go. - stocksregister.com
(CERT) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Certara stock hits 52-week low at $9.3 amid market challenges - Investing.com India
Checking Back In On Certara: Unattractive Valuation (NASDAQ:CERT) - Seeking Alpha
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities - MarketScreener
Certara unveils advanced drug development simulator - Investing.com
Certara unveils advanced drug development simulator By Investing.com - Investing.com UK
Revolutionary AI Update: How Certara's New Simcyp Platform is Transforming Drug Development - Stock Titan
Proficio Capital Partners LLC Buys Shares of 13,856 Certara, Inc. (NASDAQ:CERT) - Defense World
Why Certara, Inc. (NASDAQ:CERT) Could Be Worth Watching - simplywall.st
At US$9.91, Is Certara, Inc. (NASDAQ:CERT) Worth Looking At Closely? - Yahoo Finance
Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 - MSN
Certara Inc.: Is The Biosimulation & Software Growth Here To Stay? - Smartkarma
Commit To Buy Certara At $7.50, Earn 14.3% Annualized Using Options - Nasdaq
Raymond James Financial Inc. Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara, Inc. (NASDAQ:CERT) Receives $15.83 Consensus Price Target from Brokerages - Defense World
Certara, Inc. (NASDAQ:CERT) Shares Purchased by HighTower Advisors LLC - Defense World
Avantax Advisory Services Inc. Sells 17,660 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Charles Schwab Investment Management Inc. Grows Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
PNC Financial Services Group Inc. Raises Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Amundi Raises Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
Atria Investments Inc Reduces Position in Certara, Inc. (NASDAQ:CERT) - Defense World
US Bancorp DE Has $101,000 Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
(CERT) Technical Data - news.stocktradersdaily.com
Proficio Capital Partners LLC Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges By Investing.com - Investing.com South Africa
Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges - Investing.com Australia
Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation - Investing.com India
Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation By Investing.com - Investing.com South Africa
Certara Inc (NASDAQ: CERT) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register
Bank of New York Mellon Corp Purchases 1,253,385 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
23,568 Shares in Certara, Inc. (NASDAQ:CERT) Acquired by Private Advisor Group LLC - Defense World
Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions - citybiz
Certara announces leadership change in drug development By Investing.com - Investing.com South Africa
Certara announces leadership change in drug development - Investing.com India
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 05:07 pm EST - Marketscreener.com
Certara Announces Leadership Change with Dr. Smith’s Departure - TipRanks
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:16 pm EST - Marketscreener.com
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:15 pm EST - Marketscreener.com
Can This Former IQVIA Executive Transform Certara's Drug Development Approach? - StockTitan
Principal Financial Group Inc. Has $5.66 Million Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Objective long/short (CERT) Report - Stock Traders Daily
Q2 Earnings Estimate for Certara Issued By William Blair - Defense World
Certara (NASDAQ:CERT) Price Target Raised to $13.00 - Defense World
Q1 Earnings Estimate for Certara Issued By Leerink Partnrs - Defense World
Certara Inc (CERT) 財務データ
収益
当期純利益
現金流量
EPS
3.96%
大文字化:
|
ボリューム (24 時間):